Bivalirudin for anticoagulation during hypothermic cardiopulmonary bypass and recombinant factor VIIa for iatrogenic coagulopathy

Annals of Pharmacotherapy

Volumn 45, Issue 9, 2011, Pages

  Nagle, Erin L ^a   Tsu, Laura V ^a   Dager, William E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aortic aneurysm; Bivalirudin; Cardiopulmonary bypass; Hypothermia; rFVIIa

Indexed keywords

AMINOCAPROIC ACID; ANTICOAGULANT AGENT; FONDAPARINUX; FRESH FROZEN PLASMA; HIRULOG; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN INHIBITOR;

ADULT; ANTICOAGULATION; AORTA ANEURYSM; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CASE REPORT; COOLING; DEEP HYPOTHERMIC CIRCULATORY ARREST; DEEP VEIN THROMBOSIS; DRUG DOSE REDUCTION; DRUG EFFECT; ERYTHROCYTE CONCENTRATE; HEMOSTASIS; HUMAN; HYPERTENSION; HYPOTHERMIA; IATROGENIC DISEASE; LOADING DRUG DOSE; LOW DRUG DOSE; MALE; PATIENT MONITORING; PRIORITY JOURNAL; REPEATED DRUG DOSE; SINGLE DRUG DOSE; THORAX PAIN; THROMBOCYTE TRANSFUSION; THROMBOEMBOLISM; TREATMENT OUTCOME; WARMING;

ANTITHROMBINS; BLOOD COAGULATION DISORDERS; CARDIOPULMONARY BYPASS; CIRCULATORY ARREST, DEEP HYPOTHERMIA INDUCED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; FACTOR VIIA; FOLLOW-UP STUDIES; HIRUDINS; HUMANS; IATROGENIC DISEASE; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS;

EID: 80052499476     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P785     Document Type: Article

References (25)

1. Gravlee GP, Davis RF, Stammers AH, Ungerleider RM. Cardiopulmonary bypass: principles and practice. 3rd ed. Philadelphia: Lippincott Williams and Wilkins, 2008.
2. Warkentin TE, Greinacher A, Koster A. Bivalirudin. Thromb Haemost 2008;99:830-9. DOI 10.1160/TH07-10-0644
3. Koster A, Dyke CM, Aldea G, et al. Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial. Ann Thorac Surg 2007;83:572-7. DOI 10.1016/j.athoracsur.2006.09.038
4. Dyke CM, Smedira NG, Koster A, et al. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study. J Thorac Cardiovasc Surg 2006;131:533-9. DOI 10.1016/j.jtcvs2005.09.057
5. Riess FC, Dobritzsch B, Kormann J. Lepirudin for cardiopulmonary bypass surgery in a patient with terminal renal insufficiency and acute heparin-induced thrombocytopenia. Thorac Cardiovasc Surg 2006;54:140-2. DOI 10.1055/s-2005-872806
6. Smith AI, Stroud R, Damiani P, Vaynblat M. Use of argatroban for anticoagulation during cardiopulmonary bypass in a patient with heparin allergy. Eur J Cardiothorac Surg 2008;34:1113-4. DOI 10.1016/j.ejcts.2008.07.035
7. Koster A, Spiess B, Chew DP, et al. Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. Am J Cardiol 2004;93:356-9. DOI 10.1016/j.amjcard.2003.10.021
8. Vavra KA, Lutz MF, Smythe MA. Recombinant factor VIIa to manage major bleeding from newer parenteral anticoagulants. Ann Pharmacother 2010;44:718-26. DOI 10.1345/aph.1M447
9. Stratmann G, deSilva AM, Tseng EE, et al. Reversal of direct thrombin inhibition after cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia. Anesth Analg 2004;98:1635-9. DOI 10.1213/01.ANE.0000114072.71353.D5
10. Apostolidou I, Sweeney MF, Missov E, Joyce LD, John R, Prielipp RC. Acute left atrial thrombus after recombinant factor VIIa administration during left ventricular assist device implantation in a patient with heparin-induced thrombocytopenia. Anesth Analg 2008;106:404-8.DOI 10.1213/ane.0b013e31815edb52
11. Dager WE, Young N. Reversal of bivalirudin with recombinant activated factor VII during cardiac surgery (abstract). Thromb Thrombolysis 2011;31:393.
12. Alsoufi B, Caldarone C, Abouassaly C. Hypothermia, circulatory arrest and cardiopulmonary bypass 2007. http://emedicine.medscape.com/article/902596-overview (accessed 2010 Nov 24).
13. Shimokawa M, Kitaguichi K, Kawaguchi M, Sakamoto T, Kakimoto M, Furuya H. The influence of induced hypothermia for hemostatic function on temperature-adjusted measurements in rabbits. Anesth Analg 2003;96:1209-13. DOI 10.1213/01.ANE.0000050767.86196.AF
14. Dirkmann D, Hanke AA, Horlinger K, et al. Hypothermia and acidosis synergistically impair coagulation in human whole blood. Anesth Analg 2008;106:1627-32. DOI 10.1213/ane.0b013e31817340ad
15. Leissner KB, Ketchedjian A, Crowley R, et al. Deep hypothermic circulatory arrest and bivalirudin use in a patient with heparin-induced thrombocytopenia and antiphospholipid syndrome. J Card Surg 2007;22:78-82. DOI 10.11111/j.1540-8191.2007.00351
16. Rohrer MJ, Natale AM. Effect of hypothermia on the coagulation cascade. Crit Care Med 1992;10:1402-5.
17. Package insert. NovoSeven, Coagulation Factor VIIa (recombinant). Princeton, NJ: Novo Nordisk Pharmaceuticals, Sept. 1999.
18. O'Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 2006;295:293-8. DOI 10.1001/jama.295.3.293
19. Flynn JD, Hatton KW. Pharmacotherapy assessment program, 7th ed. Perioperative management of antithrombotic therapy. American College of Clinical Pharmacy, 2010.
20. Hardy JF, Belisle S. Natural and synthetic antifibrinolytics in adult cardiac surgery: efficacy, effectiveness and efficiency. Can J Anaesth 1994; 41:1104-12.
21. Yank V, Tuohy CV, Logan AC, et al. Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. Ann Intern Med 2011;154:529-40.
22. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians' evidence-based clinical practice guidelines (8th edition). Chest 2008;133(6 SUPPL):381S-453S. DOI 10.1378/chest.08-0656
23. Robson R, White H, Aylward P, Frampton C. Bivalirudin pharmacokinetics and pharmacodynamics: effect of renal function, dose and gender. Clin Pharmacol Ther 2002:71:433-9. DOI 10.1067/mcp.2002.124522
24. Sciulli TM, Mauro VF. Pharmacology and clinical use of bivalirudin. Ann Pharmacother 2002;36:1028-41.
25. Kessler CM. Urgent reversal of warfarin with prothrombin complex concentrate: where are the evidence-based data? J Thromb Haemost 2006;4: 963-6.